Cargando…
ODP548 Fatty acid metabolism-related factors in breast and endometrial cancers
Obesity is a well-known risk factor for gynecological malignant tumors such as breast and endometrial cancers. In the cancer microenvironment, the interaction between cancer cells and adipocytes reportedly contributes to the malignant behavior of cancer. In breast cancer, the fatty acid transporter...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629217/ http://dx.doi.org/10.1210/jendso/bvac150.1801 |
_version_ | 1784823356149727232 |
---|---|
author | Miki, Yasuhiro Naraoka, Hiyori Iwabuchi, Erina Sato, Ai Takagi, Kiyoshi Sasano, Hironobu Ishida, Takanori Suzuki, Takashi Ito, Kiyoshi |
author_facet | Miki, Yasuhiro Naraoka, Hiyori Iwabuchi, Erina Sato, Ai Takagi, Kiyoshi Sasano, Hironobu Ishida, Takanori Suzuki, Takashi Ito, Kiyoshi |
author_sort | Miki, Yasuhiro |
collection | PubMed |
description | Obesity is a well-known risk factor for gynecological malignant tumors such as breast and endometrial cancers. In the cancer microenvironment, the interaction between cancer cells and adipocytes reportedly contributes to the malignant behavior of cancer. In breast cancer, the fatty acid transporter CD36, also known as fatty acid translocase, has been shown to mediate fatty acid uptake into cancer cells and activate signaling pathways that promote tumor progression. Fatty acids are speculated to play important roles in breast and endometrial cancer; however, detailed mechanisms remain unclear. In the present study, we first examined the expression of CD36 and acyl-CoA dehydrogenase long chain (ACADL) in breast (30 cases) and endometrial (35 cases) cancer tissues using immunohistochemistry. CD36 is a membrane protein that transports long-chain fatty acids, and ACADL catalyzes the initial β-oxidation reaction. We detected no correlation between the CD36 status and clinicopathological factors, including the estrogen receptor status in breast cancer tissues. CD36 status revealed a significant positive correlation with lymph node metastasis in endometrial cancer. There was no immunoreactivity for CD36 in morphologically normal mammary glands. Otherwise, CD36 immunoreactivity was detected in the endometrial glandular cells. In both cancers, ACADL expression did not correlate with any clinicopathological factor. Both CD36 and ACADL showed higher positivity rates in endometrial cancer than in breast cancer. In addition, the effect of lipid addition on cell proliferation was examined using breast (T-47D) and endometrial (AN3CA) cancer cell lines exhibiting equivalent CD36 levels. Lipid (Refeed JNS) was obtained from Remembrane, Italy. Lipid addition promoted cell proliferation in both T-47D and AN3CA cells. Intracellular fatty acid β-oxidation (FAO) was visualized using FAOBlue (Funakoshi, Tokyo, Japan), a nonanoic acid (C9) derivative of coumarin, a blue fluorescence dye. Following FAOBlue decomposition in the fourth FAO cycle, coumarin is released from propionic acid, and released coumarin shows strong blue fluorescence excited at 405 nm. T-47D cells showed blue fluorescence in the lipid-supplemented medium, indicating β-oxidative activity. Conversely, AN3CA cells exhibited weak fluorescence under the same conditions. It can be postulated that intracellular lipid uptake and subsequent β-oxidation are mediated via a specific pathway in breast and endometrial cancers. Lipid-mediated effects differ between breast and endometrial cancers, and further investigations are needed to elucidate intracellular signals mediating these effects. Presentation: No date and time listed |
format | Online Article Text |
id | pubmed-9629217 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-96292172022-11-04 ODP548 Fatty acid metabolism-related factors in breast and endometrial cancers Miki, Yasuhiro Naraoka, Hiyori Iwabuchi, Erina Sato, Ai Takagi, Kiyoshi Sasano, Hironobu Ishida, Takanori Suzuki, Takashi Ito, Kiyoshi J Endocr Soc Tumor Biology Obesity is a well-known risk factor for gynecological malignant tumors such as breast and endometrial cancers. In the cancer microenvironment, the interaction between cancer cells and adipocytes reportedly contributes to the malignant behavior of cancer. In breast cancer, the fatty acid transporter CD36, also known as fatty acid translocase, has been shown to mediate fatty acid uptake into cancer cells and activate signaling pathways that promote tumor progression. Fatty acids are speculated to play important roles in breast and endometrial cancer; however, detailed mechanisms remain unclear. In the present study, we first examined the expression of CD36 and acyl-CoA dehydrogenase long chain (ACADL) in breast (30 cases) and endometrial (35 cases) cancer tissues using immunohistochemistry. CD36 is a membrane protein that transports long-chain fatty acids, and ACADL catalyzes the initial β-oxidation reaction. We detected no correlation between the CD36 status and clinicopathological factors, including the estrogen receptor status in breast cancer tissues. CD36 status revealed a significant positive correlation with lymph node metastasis in endometrial cancer. There was no immunoreactivity for CD36 in morphologically normal mammary glands. Otherwise, CD36 immunoreactivity was detected in the endometrial glandular cells. In both cancers, ACADL expression did not correlate with any clinicopathological factor. Both CD36 and ACADL showed higher positivity rates in endometrial cancer than in breast cancer. In addition, the effect of lipid addition on cell proliferation was examined using breast (T-47D) and endometrial (AN3CA) cancer cell lines exhibiting equivalent CD36 levels. Lipid (Refeed JNS) was obtained from Remembrane, Italy. Lipid addition promoted cell proliferation in both T-47D and AN3CA cells. Intracellular fatty acid β-oxidation (FAO) was visualized using FAOBlue (Funakoshi, Tokyo, Japan), a nonanoic acid (C9) derivative of coumarin, a blue fluorescence dye. Following FAOBlue decomposition in the fourth FAO cycle, coumarin is released from propionic acid, and released coumarin shows strong blue fluorescence excited at 405 nm. T-47D cells showed blue fluorescence in the lipid-supplemented medium, indicating β-oxidative activity. Conversely, AN3CA cells exhibited weak fluorescence under the same conditions. It can be postulated that intracellular lipid uptake and subsequent β-oxidation are mediated via a specific pathway in breast and endometrial cancers. Lipid-mediated effects differ between breast and endometrial cancers, and further investigations are needed to elucidate intracellular signals mediating these effects. Presentation: No date and time listed Oxford University Press 2022-11-01 /pmc/articles/PMC9629217/ http://dx.doi.org/10.1210/jendso/bvac150.1801 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Tumor Biology Miki, Yasuhiro Naraoka, Hiyori Iwabuchi, Erina Sato, Ai Takagi, Kiyoshi Sasano, Hironobu Ishida, Takanori Suzuki, Takashi Ito, Kiyoshi ODP548 Fatty acid metabolism-related factors in breast and endometrial cancers |
title | ODP548 Fatty acid metabolism-related factors in breast and endometrial cancers |
title_full | ODP548 Fatty acid metabolism-related factors in breast and endometrial cancers |
title_fullStr | ODP548 Fatty acid metabolism-related factors in breast and endometrial cancers |
title_full_unstemmed | ODP548 Fatty acid metabolism-related factors in breast and endometrial cancers |
title_short | ODP548 Fatty acid metabolism-related factors in breast and endometrial cancers |
title_sort | odp548 fatty acid metabolism-related factors in breast and endometrial cancers |
topic | Tumor Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629217/ http://dx.doi.org/10.1210/jendso/bvac150.1801 |
work_keys_str_mv | AT mikiyasuhiro odp548fattyacidmetabolismrelatedfactorsinbreastandendometrialcancers AT naraokahiyori odp548fattyacidmetabolismrelatedfactorsinbreastandendometrialcancers AT iwabuchierina odp548fattyacidmetabolismrelatedfactorsinbreastandendometrialcancers AT satoai odp548fattyacidmetabolismrelatedfactorsinbreastandendometrialcancers AT takagikiyoshi odp548fattyacidmetabolismrelatedfactorsinbreastandendometrialcancers AT sasanohironobu odp548fattyacidmetabolismrelatedfactorsinbreastandendometrialcancers AT ishidatakanori odp548fattyacidmetabolismrelatedfactorsinbreastandendometrialcancers AT suzukitakashi odp548fattyacidmetabolismrelatedfactorsinbreastandendometrialcancers AT itokiyoshi odp548fattyacidmetabolismrelatedfactorsinbreastandendometrialcancers |